A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale

Isakoff, SJ; Puhalla, S; Domchek, SM; Friedlander, M; Kaufman, B; Robson, M; Telli, ML; Dieras, V; Han, HS; Garber, JE; Johnson, EF; Maag, D; Qin, Q; Giranda, VL; Shepherd, SP

Isakoff, SJ (reprint author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.

FUTURE ONCOLOGY, 2017; 13 (4): 307

Abstract

Veliparib is an orally administered poly(ADP-ribose) polymerase inhibitor that is being studied in Phase I-III clinical trials, including Phase III st......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索